Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2020; 19(01): 89-91
DOI: 10.4103/wjnm.WJNM_14_19
Interesting Cases

Unexpected rare metastases of renal cell carcinoma

Alex Khoo
Department of Nuclear Medicine, Penang Adventist Hospital, Pulau Pinang, Malaysia
,
Yew Cheong
1   Department of Surgery, Penang Adventist Hospital, Pulau Pinang, Malaysia
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Renal cell carcinomas (RCCs) commonly metastasize to the lungs and bones and rarely to the parathyroid, maxillary sinus, and adrenals. It is indeed very rare to have these all these metastases occurring simultaneously in an individual. We share a case of 67-year-old woman provisionally treated for parathyroid carcinoma but subsequently found to actually have metastatic RCC to the left maxillary sinus, parathyroid, lungs, and adrenals on 18F-fluorodeoxyglucose positron emission tomography–computed tomography.

Keywords

18F-fluorodeoxyglucose - maxillary sinus - metastatic - parathyroid - positron emission tomography–computed tomography - renal cell carcinoma

Financial support and sponsorship

Nil.




Publication History

Received: 21 February 2019

Accepted: 28 May 2019

Article published online:
19 April 2022

© 2020. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144:1941-53.
  • 2 Linehan WM. Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics. Genome Res 2012;22:2089-100.
  • 3 Torregrossa L, Rotondo MI, Cacciato Insilla A, Galleri D, Guidoccio F, Miccoli P, et al. Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report. Oncol Lett 2016;12:3224-8.
  • 4 Evangelista L, Sorgato N, Torresan F, Boschin IM, Pennelli G, Saladini G, et al. FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case series. World J Clin Oncol 2011;2:348-54.
  • 5 Grimm MO, Wolff I, Zastrow S, Fröhner M, Wirth M. Advances in renal cell carcinoma treatment. Ther Adv Urol 2010;2:11-7.
  • 6 Liu Y. The place of FDG PET/CT in renal cell carcinoma: Value and limitations. Front Oncol 2016;6:201.
  • 7 Sankineni S, Brown A, Cieciera M, Choyke PL, Turkbey B. Imaging of renal cell carcinoma. Urol Oncol 2016;34:147-55.
  • 8 Wang HY, Ding HJ, Chen JH, Chao CH, Lu YY, Lin WY, et al. Meta-analysis of the diagnostic performance of [18F] FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging 2012;12:464-74.
  • 9 Gong J, Maia MC, Dizman N, Govindarajan A, Pal SK. Metastasis in renal cell carcinoma: Biology and implications for therapy. Asian J Urol 2016;3:286-92.
  • 10 Ofo E, Mandavia R, Jeannon JP, Odell E, Simo R. Renal cell carcinoma metastasis to the parathyroid gland: A very rare occurrence. Int J Surg Case Rep 2014;5:378-80.